INS and polycystic ovary syndrome: Having determined that insulin-treated or hCG-treated rats do not develop a combination of insulin resistance and hyperandrogenism, insulin+hCG-treated rats were used to examine whether aberrant lipid metabolism and hepatic dysfunction occurred when both conditions were present in a similar manner as in PCOS patients.